Disclosure Of Fair Value Measurement [Text Block]

Innate Pharma - Filing #882171

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
267 496 EUR
307 423 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
219 404 EUR
456,000 EUR
1 054 EUR
107 440 EUR
1 054 EUR
52 809 EUR
375 220 EUR
3 978 EUR
156 476 EUR
63 984 EUR
3 950 EUR
355,000 EUR
372 131 EUR
155 976 EUR
472,000 EUR
20 759 EUR
369 617 EUR
217 416 EUR
134 912 EUR
3 941 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.